Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

New 2-year data show the long-term effects of bimekizumab on hidradenitis suppurativa, indicating its potential as a valuable ...

The latest FDA approval was based on the results of the ADVANCE trial, which showed that five times as many adults with mild to moderate plaque psoriasis receiving oral Otezla 30 mg twice daily ...

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

J&J is hoping to show that the peptide drug can be a more patient-friendly alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23, such as J&J's own Tremfya ...

Feb. 3, 2025 — Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the ...

Mild cognitive impairment is when a person starts to have problems with their memory or thinking. It can be a sign of a disease that will eventually cause dementia but MCI is not dementia and can be ...

Feeling a little itchy? Here's how to recognize the most commonly undiagnosed skin irritations, including the one you may ...

However, it’s never too late for the brain to get at least some benefit from living more healthily. Mild cognitive impairment is when a person starts to have problems with their memory or thinking. It ...

Discover studies that have shown that psoriasis patients exhibit elevated intestinal permeability, correlating with ...